The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
some of these genes and Snips can be identified on regular kind of call it commercial over-the-counter tests such as 23andMe but truthfully Nick for most of our patients we're doing whole genome sequencing on this particular topic the error rate is lower and frankly most of the genes that we care about are not genes that are showing up on the shorter snip tests
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.